Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • CXCR
    (1)
  • Discoidin Domain Receptor (DDR)
    (1)
  • Endogenous Metabolite
    (1)
  • HCV Protease
    (1)
  • Histone Methyltransferase
    (1)
  • LRRK2
    (1)
  • Molecular Glues
    (1)
  • PROTACs
    (1)
  • PSMA
    (1)
  • Others
    (58)
Filter
Search Result
Results for "

exceptional

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    84
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    2
    TargetMol | Peptide_Products
  • Dye Reagents
    15
    TargetMol | Dye_Reagents
  • PROTAC Products
    2
    TargetMol | PROTAC
  • Natural Products
    3
    TargetMol | Natural_Products
  • Cell Research
    6
    TargetMol | Inhibitors_Agonists
jnk3 inhibitor-4
T727152409109-65-3In house
JNK3 Inhibitor-4, a potent 2-aryl-1-pyrimidinyl-1H-imidazole-5-yl acetonitrile derivative, demonstrates a strong inhibitory effect on JNK3 with an IC 50 value of 1.0 nM. It exhibits exceptional selectivity against JNK3 when compared to other protein kinases, including isoforms JNK1 (IC 50 = 143.9 nM) and JNK2 (IC 50 = 298.2 nM). Additionally, JNK3 Inhibitor-4 benefits from neuroprotective properties and is predicted to permeate the blood-brain barrier effectively.
  • Inquiry Price
6-8 weeks
Size
QTY
EEDi-5285
UM-EEDi-5285, EEDI5285
T223222488952-40-3
EEDi-5285, an orally active and highly potent inhibitor targeting embryonic ectoderm development (EED) protein, exhibits anti-cancer activity. It demonstrates exceptional efficacy with an IC50 value of 0.2 nM, indicating robust binding affinity to the EED protein.
  • Inquiry Price
Size
QTY
Linolelaidic acid
Linoelaidic acid, (9E,12E)-octadeca-9,12-dienoic acid
TN7008506-21-8
Linolelaidic acid ((9E,12E)-octadeca-9,12-dienoic acid) is a major positive regulator of CTL activity, an essential nutrient for humans, with anti-inflammatory and anti-parasitic properties. It improves metabolic adaptability, prevents fatigue, and stimulates memory-like phenotypes with exceptional effects. It induces apoptosis and can be used in infection studies.
  • Inquiry Price
Size
QTY
JH-LPH-28
T117152414592-36-0
JH-LPH-28, a sulfonyl piperazine analog, is a potent inhibitor of UDP-2,3-diacylglucosamine pyrophosphate hydrolase LpxH, exhibiting exceptional antibiotic activity with a minimum inhibitory concentration (MIC) of 0.83 μg mL.
  • Inquiry Price
Size
QTY
Cetaben
T1493355986-43-1
Cetaben, a PPARα-independent peroxisome proliferator, is a non-fibrotic lipid-lowering drug that effectively reduces cholesterol and triglyceride concentrations.
  • Inquiry Price
Size
QTY
MLi-2
T161151627091-47-7
MLi-2 is a structurally novel, highly potent, and selective LRRK2 kinase inhibitor with central nervous system activity. MLi-2 exhibits exceptional potency in a purified LRRK2 kinase assay in vitro (IC50 = 0.76 nM), a cellular assay monitoring dephosphorylation of LRRK2 pSer935 LRRK2 (IC50 = 1.4 nM), and a radioligand competition binding assay (IC50 = 3.4 nM).
  • Inquiry Price
Size
QTY
ITIC
T193861664293-06-4
ITIC, a non-fullerene acceptor, demonstrates exceptional thermal stability and exhibits a glass-crystal transition at a significantly lower temperature than its high glass transition temperature (Tg) of 180 °C. Furthermore, ITIC, which is an indacenodithienothiophene-based postfullerene electron acceptor, displays a distinct crystallization behavior, differing substantially from that of fullerenes.
  • Inquiry Price
Size
QTY
Isopyrazam
T201235881685-58-1
Isopyrazam, a plant protection product, exhibits potent antifungal activity. When applied to crops, it effectively inhibits the growth of various plant pathogenic fungi, significantly enhancing both the yield and quality of the crops. This compound demonstrates exceptional disease resistance capabilities in agricultural applications.
  • Inquiry Price
6-8 weeks
Size
QTY
RR-49
RR49, RR 49
T2024882376328-79-7
RR-49 is an innovative difluorinated analogue. This compound demonstrates exceptional pH sensitivity, showing the same efficacy for DAMGO in MOR cAMP assays at pH 6.5 as it does at pH 7.4, but with a 19-fold increase in potency (IC50). It holds significant promise as an analgesic for treating inflammatory pain with a lower potential for abuse.
  • Inquiry Price
Size
QTY
LB 11058
LB-11058, LB11058
T202679591207-81-7
LB 11058 is a novel injectable cephalosporin featuring a C-3 pyridyl-substituted vinyl sulfide and a C-7 2-amino-5-chloro-1,3-thiazole group. This compound exhibits exceptional activity against Streptococcus pneumoniae and demonstrates similar efficacy against β-hemolytic streptococci. The inhibition pattern for LB 11058 with S. aureus is consistent, as all isolates are inhibited under this pattern.
  • Inquiry Price
Size
QTY
UNC8969
UNC 8969, UNC-8969
T202988
UNC8969 is a macrocyclic dual MERTK AXL inhibitor (IC50 MERTK = 1.1 nM; IC50 AXL = 5.3 nM). The compound exhibits low nanomolar activity against MERTK and AXL while demonstrating good selectivity over TYRO3 and FLT3. Target binding and selectivity have been confirmed through NanoBRET and cell-based MERTK and AXL phosphorylation assays. UNC8969 possesses excellent pharmacokinetic properties (large AUC and long half-life) and shows exceptional anti-tumor activity against lung cancer cell lines, indicating its potential as a therapeutic compound.
  • Inquiry Price
Size
QTY
PSMA-D5
T2030233056440-83-3
PSMA-D5 exhibits a binding affinity for PSMA with a Ki of 0.21 nM and becomes useful for PSMA tracing following radiolabeling. When marked with [68Ga], PSMA-D5 contains a DOTA chelator, facilitating the convenient labeling with therapeutic radionuclides such as 177Lu and 225Ac. Additionally, [68Ga]-labeled PSMA-D5 demonstrates exceptional pharmacokinetic properties and significant tumor uptake in 22Rv1 tumors. This compound can be employed in the synthesis and research of radiolabeled conjugates (RDC).
  • Inquiry Price
Size
QTY
4A3-SCC-PH
T203780
4A3-SCC-PH is a degradable ionic lipid (LDIL) characterized by a unique cone-shaped structure responsive to GSH. This configuration enables exceptional endosomal escape and rapid mRNA release.
  • Inquiry Price
Size
QTY
HPK1-IN-55
T2045203048537-58-9
HPK1-IN-55 (compound 19) is a selective and orally active inhibitor of hematopoietic progenitor kinase 1 (HPK1) with an IC50 of less than 0.51 nM. It exhibits exceptional kinase selectivity, being over 637 times more selective for HPK1 compared to GCK kinase and over 1022 times compared to LCK. HPK1-IN-55 possesses anti-cancer properties.
  • Inquiry Price
10-14 weeks
Size
QTY
LYG-409
T2053493053857-55-6
LYG-409 is an orally active GSPT1 degrader. It demonstrates exceptional in vivo anti-tumor activity against acute myeloid leukemia and prostate cancer, with tumor growth inhibition rates (TGI) of 94.34% and 104.49%, respectively. LYG-409 inhibits KG-1 cells by degrading GSPT1, with an IC50 of 9.50 nM and a DC50 of 7.87 nM in vitro.
  • Inquiry Price
Size
QTY
SDH-IN-23
T205598
SDH-IN-23 (Compound B21) is an SDH inhibitor with exceptional nematicidal activity. It can suppress nematode feeding, reproduction, and embryonic development while also inducing lethal effects through mechanisms such as oxidative stress, intestinal damage, and SDH inhibition.
  • Inquiry Price
Size
QTY
GSK-114
T223411301761-96-5
GSK-114, a selective inhibitor of TNNI3 Interacting Kinase (TNNI3K) with IC50 of 25 nM, shows significant bias for TNNI3K over B-Raf with IC50 of 1000 nM, exceptional broad spectrum kinase selectivity and adequate oral exposure to enable its use in cellul
  • Inquiry Price
Size
QTY
s-14671
T28641135722-27-9
S-14671 is a 5-HT1A receptor agonist (pKi = 9.3) with high efficacy and exceptional in vivo potency. S-14671 also acts as a 5-HT2A and 5-HT2C receptor antagonist (both are pKi = 7.8).
  • Inquiry Price
6-8 weeks
Size
QTY
QTX125
T356611279698-31-5
QTX125, a powerful and highly specific HDAC6 inhibitor, demonstrates exceptional selectivity in comparison to other HDACs, resulting in robust antitumor activity[1].
  • Inquiry Price
6-8 weeks
Size
QTY
Cucurbit[8]uril
T35862259886-51-6
Cucurbit[8]uril is a highly effective and safe supramolecular compound that promotes protein heterodimerization. It selectively induces the heterodimerization of methylviologen and naphthalene functionalized proteins, demonstrating its specificity and versatility. Additionally, Cucurbit[8]uril shows exceptional oral activity and low toxicity, making it a promising candidate for various pharmaceutical and biotechnological applications.
  • Inquiry Price
Size
QTY
(Rac)-Finerenone
(Rac)-Finerenone,(Rac)-BAY 94-8862
T384481050477-27-4
Rac-Finerenone, also known as (Rac)-BAY 94-8862, is the racemate derivative of Finerenone, a selective third-generation nonsteroidal mineralocorticoid receptor antagonist (MR) that is taken orally. With an IC50 value of 18 nM, Finerenone exhibits exceptional selectivity against the glucocorticoid receptor (GR), androgen receptor (AR), and progesterone receptor (>500-fold).
  • Inquiry Price
Size
QTY
4-APC hydrobromide
T384661076196-38-7
4-APC hydrobromide is a potent and specific aldehyde derivatization agent. It contains an aniline moiety that enables rapid and selective reaction with aliphatic aldehydes, as well as a quaternary ammonium group that enhances sensitivity in mass spectrometry (MS) analysis. By utilizing 4-APC hydrobromide, aldehydes can be detected with exceptional sensitivity and selectivity using MS.
  • Inquiry Price
7-10 days
Size
QTY
Ascr#7
T385151139837-37-8
Ascr#7, an ascaroside-based hormonal compound, plays a significant role in nematode physiology. It is specifically expressed throughout the various stages of nematode development. Notably, ascarosides exhibit the capability to initiate the formation of dauer larvae, which are characterized by their long lifespan and exceptional stress resistance.
  • Inquiry Price
Size
QTY
ALK-IN-12
T385841197958-53-4
ALK-IN-12 is a highly potent and orally active inhibitor of anaplastic lymphoma kinase (ALK), demonstrating an exceptional IC50 value of 0.18 nM. Additionally, ALK-IN-12 displays inhibitory activity against insulin-like growth factor 1 receptor (IGF1R) and insulin receptor (InsR), with IC50 values of 20.3 nM and 90.6 nM, respectively. Notably, its antitumor effects have been observed, making it a promising compound for targeted cancer therapy.
  • Inquiry Price
Size
QTY